510(k) Report

510(k) · Cleared

Cleared

Urea Nitrogen2

K203771510(k) TraditionalCleared May 31, 2022524-day reviewClass II21 CFR 862.1770

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Ireland Diagnostics Division · CDQ Urease And Glutamic Dehydrogenase, Urea Nitrogen

Cleared on May 31, 2022 as substantially equivalent to K981918 (Abbott Laboratories, 1998) after a 524-day review. Its family tree reaches back 2 generations to 1977.

Decided
May 31, 2022
Review
524 days
Class
Class II
Product code
CDQ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K771923 (1977). No later device cites it as a predicate yet.

  1. Root · 2 generations backK771923 Fastchem BunBoehringer Mannheim Corp. · 1977
  2. 1 generation backK981918 UREAAbbott Laboratories · 1998 · Recalled
  3. This deviceK203771 Urea Nitrogen2Abbott Ireland Diagnostics Division · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K771923Fastchem BunBoehringer Mannheim Corp.1977—
−1K981918UREAAbbott Laboratories19981
0 (this device)K203771Urea Nitrogen2Abbott Ireland Diagnostics Division2022—
FIG. 1 — Lineage of K203771, 1977–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CDQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K981918UREA
Summary page 5
…n Name: Urease and Glutamic Dehydrogenase, Urea Nitrogen Governing Regulation Number: 21 CFR 862.1770 Product Code: CDQ IV. Predicate Device Urea Nitrogen (k981918) V. Description of Device A. Principles of the Procedure The Urea Nitrogen2 assay is an automated clinical chemist…
Abbott Laboratories19981

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 45 years and passes through 3 companies; a new generation was cleared every 23.8 years on median.
  • 1 of the 2 ancestors has a recall of any class.

How does its category compare?

All CDQ devices

CDQ Urease And Glutamic Dehydrogenase, Urea Nitrogen: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · CDQ

1in 2022

2007: 12008: 12011: 12014: 12022: 1
2007high 1 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CDQ

Too few CDQ 510(k)s in any year since 2007 to give a median.

Recalls per year · CDQ

1in 2011

2011: 1
2007high 1 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CDQ

6in 2025

2010: 62011: 372012: 442013: 12015: 12016: 2312020: 32021: 12022: 12023: 22024: 42025: 6
2007high 231 (2016) · low 0 (2007)2025

MAUDE reports naming product code CDQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20081—00
20090—00
20100—06
20111—137
20120—044
20130—01
20141—00
20150—01
20160—0231
20170—00
20180—00
20190—00
20200—03
20210—01
20221—01
20230—02
20240—04
20250—06
20260—0—

What is it indicated for?

The Urea Nitrogen2 assay is used for the quantitation of Urea Nitrogen in human serum, plasma, or urine on the

ARCHITECT c System.

The Urea Nitrogen2 assay is to used as an aid in the diagnosis and treatment of certain renal and metabolic diseases.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K203771: Urea Nitrogen2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K203771

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026